These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 9927194
1. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Shtil AA, Mandlekar S, Yu R, Walter RJ, Hagen K, Tan TH, Roninson IB, Kong AN. Oncogene; 1999 Jan 14; 18(2):377-84. PubMed ID: 9927194 [Abstract] [Full Text] [Related]
2. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Stone AA, Chambers TC. Exp Cell Res; 2000 Jan 10; 254(1):110-9. PubMed ID: 10623471 [Abstract] [Full Text] [Related]
3. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Yu W, Liao QY, Hantash FM, Sanders BG, Kline K. Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656 [Abstract] [Full Text] [Related]
4. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. Hsu YL, Kuo PL, Lin LT, Lin CC. J Pharmacol Exp Ther; 2005 Apr 01; 313(1):333-44. PubMed ID: 15626723 [Abstract] [Full Text] [Related]
5. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest. Gajate C, Barasoain I, Andreu JM, Mollinedo F. Cancer Res; 2000 May 15; 60(10):2651-9. PubMed ID: 10825137 [Abstract] [Full Text] [Related]
6. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Xiao D, Pinto JT, Soh JW, Deguchi A, Gundersen GG, Palazzo AF, Yoon JT, Shirin H, Weinstein IB. Cancer Res; 2003 Oct 15; 63(20):6825-37. PubMed ID: 14583480 [Abstract] [Full Text] [Related]
8. Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis. The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis. Kong AN, Yu R, Lei W, Mandlekar S, Tan TH, Ucker DS. Restor Neurol Neurosci; 1998 Jun 15; 12(2-3):63-70. PubMed ID: 12671299 [Abstract] [Full Text] [Related]
10. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Mandlekar S, Yu R, Tan TH, Kong AN. Cancer Res; 2000 Nov 01; 60(21):5995-6000. PubMed ID: 11085519 [Abstract] [Full Text] [Related]
12. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Yu R, Jiao JJ, Duh JL, Tan TH, Kong AN. Cancer Res; 1996 Jul 01; 56(13):2954-9. PubMed ID: 8674048 [Abstract] [Full Text] [Related]
13. c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells. Chen J, Sun WL, Wasylyk B, Wang YP, Zheng H. Anticancer Drugs; 2012 Jan 01; 23(1):98-107. PubMed ID: 21968419 [Abstract] [Full Text] [Related]
14. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T, Wimalasena J. J Biol Chem; 1998 Feb 27; 273(9):4928-36. PubMed ID: 9478937 [Abstract] [Full Text] [Related]
15. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ. Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418 [Abstract] [Full Text] [Related]
16. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. Huang Y, Sheikh MS, Fornace AJ, Holbrook NJ. Oncogene; 1999 Jun 10; 18(23):3431-9. PubMed ID: 10376521 [Abstract] [Full Text] [Related]
17. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. Jun CD, Oh CD, Kwak HJ, Pae HO, Yoo JC, Choi BM, Chun JS, Park RK, Chung HT. J Immunol; 1999 Mar 15; 162(6):3395-401. PubMed ID: 10092794 [Abstract] [Full Text] [Related]
19. Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase. Calastretti A, Bevilacqua A, Ceriani C, Viganò S, Zancai P, Capaccioli S, Nicolin A. Oncogene; 2001 Sep 27; 20(43):6172-80. PubMed ID: 11593425 [Abstract] [Full Text] [Related]
20. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA, Di X, Walker TD, Sawyer ST. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]